Evidence 1
Activity
Activity
10% Hemolysis
Toxicity
32.07 µM
Hemolytic
Cytotoxic
10% Hemolysis | 32.07 | µM | target cell: Horse erythrocytes
Target
Horse erythrocytes
Source & Reference
NA
DBAASP
Modification and Targeted Design of N-Terminal Truncates Derived from Brevinin with Improved Therapeutic Efficacy | Biology (Basel) | 2020